Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 3
2006 4
2007 3
2008 2
2009 1
2010 6
2011 7
2012 3
2013 5
2014 7
2015 7
2016 8
2017 7
2018 4
2019 5
2020 13
2021 6
2022 11
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection.
Zeeb M, Frischknecht P, Huber M, Schenkel CD, Neumann K, Leeman C, Notter J, Rauch A, Stöckle M, Cavassini M, Bernasconi E, Braun DL, Günthard HF, Metzner KJ, Kouyos RD. Zeeb M, et al. Among authors: metzner kj. J Infect Dis. 2024 Mar 20:jiae149. doi: 10.1093/infdis/jiae149. Online ahead of print. J Infect Dis. 2024. PMID: 38507572 Free article.
T-Cell Exhaustion in HIV-1/Hepatitis C Virus Coinfection Is Reduced After Successful Treatment of Chronic Hepatitis C.
Caraballo Cortés K, Osuch S, Perlejewski K, Radkowski M, Janiak M, Berak H, Rauch A, Fehr JS, Hoffmann M, Günthard HF, Metzner KJ. Caraballo Cortés K, et al. Among authors: metzner kj. Open Forum Infect Dis. 2023 Oct 21;10(11):ofad514. doi: 10.1093/ofid/ofad514. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 37953817 Free PMC article.
Mycobacterium tuberculosis infection associated immune perturbations correlate with antiretroviral immunity.
Tepekule Mueller B, Joerimann L, Schenkel CD, Opitz L, Tschumi J, Wolfensberger R, Neumann K, Kusejko K, Zeeb M, Boeck L, Kaelin M, Notter J, Furrer H, Hoffmann M, Hirsch HH, Calmy A, Cavassini M, Labhardt ND, Bernasconi E, Metzner KJ, Braun DL, Guenthard HF, Kouyos RD, Duffy F, Nemeth J; Swiss HIV Cohort Study. Tepekule Mueller B, et al. Among authors: metzner kj. bioRxiv [Preprint]. 2024 Mar 3:2023.07.14.548872. doi: 10.1101/2023.07.14.548872. bioRxiv. 2024. PMID: 37649906 Free PMC article. Preprint.
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV): A Study Combining Modelling and Swiss HIV Cohort Data.
Berton M, Bettonte S, Stader F, Decosterd L, Tarr PE, Livio F, Cavassini M, Braun DL, Kusejko K, Hachfeld A, Bernasconi E, Calmy A, Schmid P, Battegay M, Marzolini C; Swiss HIV Cohort Study. Berton M, et al. Clin Infect Dis. 2024 Jan 25;78(1):98-110. doi: 10.1093/cid/ciad495. Clin Infect Dis. 2024. PMID: 37602428 Free PMC article.
Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018.
Jaha B, Schenkel CD, Jörimann L, Huber M, Zaheri M, Neumann K, Leemann C, Calmy A, Cavassini M, Kouyos RD, Günthard HF, Metzner KJ; Swiss HIV Cohort Study. Jaha B, et al. Among authors: metzner kj. J Antimicrob Chemother. 2023 Sep 5;78(9):2323-2334. doi: 10.1093/jac/dkad240. J Antimicrob Chemother. 2023. PMID: 37545164 Free PMC article.
Absence of Proviral Human Immunodeficiency Virus (HIV) Type 1 Evolution in Early-Treated Individuals With HIV Switching to Dolutegravir Monotherapy During 48 Weeks.
Jörimann L, Tschumi J, Zeeb M, Leemann C, Schenkel CD, Neumann K, Chaudron SE, Zaheri M, Frischknecht P, Neuner-Jehle N, Kuster H, Braun DL, Grube C, Kouyos R, Metzner KJ, Günthard HF; Swiss HIV Cohort Study (SHCS). Jörimann L, et al. Among authors: metzner kj. J Infect Dis. 2023 Oct 3;228(7):907-918. doi: 10.1093/infdis/jiad292. J Infect Dis. 2023. PMID: 37498738 Free PMC article.
Sustained Viral Suppression With Dolutegravir Monotherapy Over 192 Weeks in Patients Starting Combination Antiretroviral Therapy During Primary Human Immunodeficiency Virus Infection (EARLY-SIMPLIFIED): A Randomized, Controlled, Multi-site, Noninferiority Trial.
West E, Zeeb M, Grube C, Kuster H, Wanner K, Scheier T, Neumann K, Jörimann L, Hampel B, Metzner KJ, Kouyos RD, Braun DL, Günthard HF. West E, et al. Among authors: metzner kj. Clin Infect Dis. 2023 Oct 5;77(7):1012-1020. doi: 10.1093/cid/ciad366. Clin Infect Dis. 2023. PMID: 37338148 Free PMC article. Clinical Trial.
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2).
Griessbach A, Chammartin F, Abela IA, Amico P, Stoeckle MP, Eichenberger AL, Hasse B, Braun DL, Schuurmans MM, Müller TF, Tamm M, Audigé A, Mueller NJ, Rauch A, Günthard HF, Koller MT, Trkola A, Epp S, Amstutz A, Schönenberger CM, Taji Heravi A, Kusejko K, Bucher HC, Briel M, Speich B; Swiss HIV Cohort Study and the Swiss Transplant Cohort Study. Griessbach A, et al. Open Forum Infect Dis. 2023 Mar 30;10(4):ofad150. doi: 10.1093/ofid/ofad150. eCollection 2023 Apr. Open Forum Infect Dis. 2023. PMID: 37035486 Free PMC article.
104 results